glp-1 drug news Alarming rise in weight loss overdoses obesity drug news today glp-1

The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.

Powerful Probiotic Blend - Berberine makes it easier to maintain weight goals, Chicory (prebiotic fiber) promotes gut health, Probiotics balance belly bacteria, and Turmeric reduces discomfort via antioxidant benefits

It helps maintain gut health, support metabolic performance, and promote immune and internal balance over time.

Since type 2 diabetes mellitus (T2DM) is a risk factor for Alzheimers disease (AD) and both have the same pathogenesis (e.g., insulin resistance), drugs used to treat T2DM have been gradually found to reduce the progression of AD in AD models

CMS GLP-1 Bridge Program: Medicare Part D coverage for weight-loss GLP-1 drugs starting July 1, 2026, including eligibility, covered medications, prior authorization, and copay rules.